Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure

Cynthia Rusk, Elizabeth Sharpe, Jean Laurence, Adam Polis, Ingrid Adamsons

Open source

DOI
10.1016/s0149-2918(98)80055-6
Published
1998-05
Container
Clinical Therapeutics
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0149-2918-98-80055-6,
  title = {Comparison of the efficacy and safety of 2\% dorzolamide and 0.5\% betaxolol in the treatment of elevated intraocular pressure},
  author = {Cynthia Rusk and Elizabeth Sharpe and Jean Laurence and Adam Polis and Ingrid Adamsons},
  year = {1998},
  journal = {Clinical Therapeutics},
  doi = {10.1016/s0149-2918(98)80055-6},
  url = {https://doi.org/10.1016/s0149-2918(98)80055-6}
}

RIS

TY  - JOUR
TI  - Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure
AU  - Cynthia Rusk
AU  - Elizabeth Sharpe
AU  - Jean Laurence
AU  - Adam Polis
AU  - Ingrid Adamsons
PY  - 1998
JO  - Clinical Therapeutics
DO  - 10.1016/s0149-2918(98)80055-6
UR  - https://doi.org/10.1016/s0149-2918(98)80055-6
ER  - 

APA

Rusk, C., Sharpe, E., Laurence, J., Polis, A., & Adamsons, I. (1998). Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure. Clinical Therapeutics. https://doi.org/10.1016/s0149-2918(98)80055-6

Source records